You are here

Dvora Teitelbaum

Prof. Michael Sela
from the institute to Teva Pharmaceuticals Ltd.
Genes that affect reponses of MS to Copaxone

Israeli scientists identify: Genes that Affect Responses of Multiple Sclerosis Patients to Copaxone®

Cop 1 (Copaxone®): The Story of a Drug

Nearly three decades after a surprising discovery, Copaxone® gets FDA approval for the treatment of MS

Prof. Ruth Arnon
REHOVOT, Israel -- January 28, 1997 -- This week, two scientists from Israel's Weizmann Institute were honored for an...